Evaluation of Radiesse® Dermal Filler for Hand Treatment
Completed · Not applicable
Conditions studied: Aging Hands
In brief
The purpose of this study is to assess the safety and effectiveness of Radiesse® Injectable Dermal Filler for hand treatment.
Key facts
- Study ID
- NCT01832090
- Run by
- Merz North America, Inc.
- People needed
- 118
- Starts
- 2013-03-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2017-10-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Has right and left hands with rating of 2 or 3 on the Merz Hand Grading Scale (MHGS) as determined by a live, masked evaluator
- Is at least 18 years of age
You may not qualify if…
- Has history of hypertropic scarring
- Has a known bleeding disorder or receiving medication that will increase the risk of bleeding as the result of injection
- Has a known hypersensitivity to any of the components of Radiesse or local anesthesia
- Has received in past 6 months or plans to receive during the study dermal resurfacing procedure (chemical peel, dermabrasion, ablative laser resurfacing) or non-invasive skin tightening (Thermage®) in the dorsum of the hands
- Has received in past 2 weeks or plans to receive during the study prescription wrinkle therapies, topical steroids, skin irritating topical preparations, or pigmenting agents (self-tanning agents) in the dorsum of the hands
- Has had any dermal fillers or surgery in the dorsum of the hand
Where it is running
- Merz Investigative Site #004 — San Diego, California, United States
- Merz Investigative Site #007 — Vista, California, United States
- Merz Investigative Site #002 — Garden City, New York, United States
- Merz Investigative Site #006 — New York, New York, United States
- Merz Investigative Site #003 — Nashville, Tennessee, United States
- Merz Investigative Site #001 — Plano, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.